In 2020, right before the COVID pandemic really got going, @CarlJune and I debated
#Cell #immunotherapy vs
#bispecific #TcellEngagers. I think many of the points we discussed and debated will play out over the next few years. Powerful technologies that are already helping cancer patients, but also will benefit from a great deal of additional development.
#CART #cancer